{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:57:51Z","timestamp":1780451871919,"version":"3.54.1"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,9,15]]},"DOI":"10.2169\/internalmedicine.6730-20","type":"journal-article","created":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T22:06:48Z","timestamp":1617574008000},"page":"2967-2971","source":"Crossref","is-referenced-by-count":3,"title":["Dramatic Response to Carboplatin Plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis"],"prefix":"10.2169","volume":"60","author":[{"given":"Naohiro","family":"Oda","sequence":"first","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan"},{"name":"Department of Internal Medicine, Fukuyama City Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tabata","sequence":"additional","affiliation":[{"name":"Center for Clinical Oncology, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kaneda Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Umeda","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic Surgery, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironari","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Kubo","sequence":"additional","affiliation":[{"name":"Center for Clinical Oncology, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Senoo","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic Surgery, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Kiura","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 23: 410-422, 1999.","DOI":"10.1097\/00000478-199904000-00005"},{"key":"2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","volume":"17","author":"M Tanaka","year":"2017","unstructured":"2. Tanaka M, Fern\u00e1ndez-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 17: 738-753, 2017.","journal-title":"Pancreatology","ISSN":"https:\/\/id.crossref.org\/issn\/1424-3903","issn-type":"print"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67: 789-804, 2018.","DOI":"10.1136\/gutjnl-2018-316027"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Brunetti O, Aprile G, Marchetti P, et al. Systemic chemotherapy for advanced rare pancreatic histotype tumors: a retrospective multicenter analysis. Pancreas 47: 759-771, 2018.","DOI":"10.1097\/MPA.0000000000001063"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Doulamis IP, Mylonas KS, Kalfountzos CE, Mou D, Haj-Ibrahim H, Nasioudis D. Pancreatic mucinous cystadenocarcinoma: epidemiology and outcomes. Int J Surg 35: 76-82, 2016.","DOI":"10.1016\/j.ijsu.2016.09.017"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol 2: 1026-1031, 2004.","DOI":"10.1016\/S1542-3565(04)00450-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 247: 571-579, 2008.","DOI":"10.1097\/SLA.0b013e31811f4449"},{"key":"8","unstructured":"8. Obayashi K, Ohwada S, Sunose Y, et al. Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas. Gan To Kagaku Ryoho (Cancer Chemother) 35: 1915-1917, 2008 (in Japanese, Abstract in English)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. DiMarco M, Vecchiarelli S, Macchini M, et al. Preoperative gemcitabine and oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma. Case Rep Gastroenterol 6: 530-537, 2012.","DOI":"10.1159\/000341513"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pearl ML, Valea F, Chumas J, Chalas E. Primary retroperitoneal mucinous cystadenocarcinoma of low malignant potential: a case report and literature review. Gynecol Oncol 61: 150-152, 1996.","DOI":"10.1006\/gyno.1996.0115"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kessler TM, Kessler W, Neuweiler J, Nachbur BH. Treatment of a case of primary retroperitoneal mucinous cystadenocarcinoma: is adjuvant hysterectomy and bilateral salpingo-oophorectomy justified? Am J Obstet Gynecol 187: 227-232, 2002.","DOI":"10.1067\/mob.2002.119809"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Ohtsuka T, Nakamura M, Hijioka S, et al. Prediction of the probability of malignancy in mucinous cystic neoplasm of the pancreas with ovarian-type stroma: a nationwide multicenter study in Japan. Pancreas 49: 181-186, 2020.","DOI":"10.1097\/MPA.0000000000001475"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/18\/60_6730-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:39:42Z","timestamp":1715143182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/18\/60_6730-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":12,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6730-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"article-number":"6730-20"}}